ARTICLE | Clinical News
Brilacidin: Phase IIb start
December 3, 2012 8:00 AM UTC
Early next year, PolyMedix said it plans to begin a dose-optimization Phase IIb trial of single dose and 3-day dosing regimens of brilacidin. At a Type B pre-NDA meeting with FDA, PolyMedix said the a...